Rhesus rotavirus vaccine effectiveness and factors associated with receipt of vaccine

Pediatric Infectious Disease Journal

Volumn 25, Issue 11, 2006, Pages 1013-1018

  Staat, Mary Allen ^a,f   Cortese, Margaret M ^b   Bresee, Joseph S ^c   Bégué, Rodolfo E ^d   Vitek, Charles ^b,g   Rhodes, Philip ^b,g   Zhang, Rongping ^b   Gentsch, Jon ^c   Roberts, Nancy E ^a   Jaeger, Jenifer L ^e   Ward, Richard ^a   Bernstein, David I ^a   Dennehy, Penelope H ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HASBRO CHILDREN'S HOSPITAL   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute gastroenteritis; RotaShield; Rotavirus; Vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GASTROENTERITIS; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS GASTROENTERITIS; VACCINATION; VIRUS INFECTION;

ANIMALS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TREATMENT OUTCOME;

EID: 33750436954     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000243193.93355.e5     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48:1-23.
2. American Academy of Pediatrics. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine: American Academy of Pediatrics. Pediatrics. 1998;102:1483-1491.
3. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine, United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48:577-581.
4. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48:1007.
5. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus human reassortant rotavirus vaccines: report of the National Multicenter Trial. Pediatrics. 1996;97:7-13.
6. Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr. 1997;131:632-638.
7. Joensuu J, Koskenniemi E, Pang XL, et al. Randomised placebo-controlled trial of rhesus-human reassortment rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350:1205-1209.
8. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337:1181-1187.
9. Clemens J, Brenner R, Rao M, et al. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA. 1996;275:390-397.
10. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63:1055-1068.
11. Chen RT, Orenstein W. Epidemiologic methods in immunization programs. Epidemiol Rev. 1996;18:99-117.
12. Comstock GW. Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiol Rev. 1994;16:77-89.
13. Smith PJ, Schwartz B, Mokdad A, et al. The first oral rotavirus vaccine 1998-1999: estimates of uptake from the National Immunization Survey. Public Health Rep. 2003;118:134-143.
14. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21:221-227.
15. Hsu VP, Staat MA, Roberts N, et al. Use of active surveillance to validate ICD code estimates of rotavirus hospitalizations in children. Pediatrics. 2005;115:78-82.
16. Pérez Mato SP, Perrin K, Scardino D, Bégué RE. Evaluation of rotavirus vaccine effectiveness in a pediatric group practice. Am J Epidemiol. 2002;156:1049-1055.
17. Gentsch JR, Woods PA, Ramachandrab M, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis. 1996;174(suppl 1):S30-S36.
18. Venzon DJ, Moolgavkar SH. A method for computing profile-likelihood based confidence intervals. Appl Stat. 1988;37:87-94.
19. Bernstein DI, Glass RI, Rodgers G, et al. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA. 1995;273:1191-1196.
20. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities or rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine. 1999;2207-2222.
21. De Vos B, Vesikari T, Linhares AC, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J. 2004;23:S179-S182.
22. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
23. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
24. Centers for Disease Control and Prevention. CDC's Advisory Committee recommends new vaccine to prevent rotavirus today: CDC Media Relations press release. Available at: http://www.cdc.gov/nip/pr/pr_rotavirus_feb2006.htm. Accessed April 27, 2006.